Interferon-α-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax
- 17 July 2003
- journal article
- Published by Springer Nature in Oncogene
- Vol. 22 (29) , 4543-4556
- https://doi.org/10.1038/sj.onc.1206503
Abstract
We have recently reported that the cytokine interferon-alpha (IFNalpha), commonly used in the treatment of cancer, induced a caspase-dependent apoptosis in tumor cell lines. The signaling mechanisms involved have not been defined. Here, we show that both proapoptotic Bcl-2 family members Bak and Bax were activated by IFNalpha, strictly in correlation with the induction of apoptosis. Using double stainings, we demonstrated that Bak was activated prior to cytochrome c (cyt c) release and caspase-3 activation, whereas activated Bax was only found in cells with released cyt c, mitochondrial depolarization, as well as activated caspase-3. Furthermore, IFNalpha-induced activation of Bak, and to a large extent also of Bax, was dependent on caspase activity. With the use of a panel of specific caspase inhibitors we found, however, that none of caspases-1 to -10 were responsible for this activation. Neither was the Ca(2+)-dependent protease calpain nor the stress-activated p38 SAPK pathway significantly involved. Overexpression of Bcl-2 blocked apoptosis induced by IFNalpha totally abolished Bak activation, as well as decreased the amount of activated Bax. We conclude that IFNalpha induces Bak and Bax activation via distinct mechanisms involving an unknown protease, and that their activation is regulated by Bcl-2.Keywords
This publication has 34 references indexed in Scilit:
- Activation of Bak, Bax, and BH3-only Proteins in the Apoptotic Response to DoxorubicinJournal of Biological Chemistry, 2002
- Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemiaBlood, 2002
- A Role for Mitochondrial Bak in Apoptotic Response to Anticancer DrugsJournal of Biological Chemistry, 2001
- Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-α2a) plus an anthracycline-based induction regimenLeukemia, 2001
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- How Does Interferon-Alpha Exert Its Antitumour Activity in Multiple Myeloma?Acta Oncologica, 2000
- From receptors to stress-activated MAP kinasesOncogene, 1999
- Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of ApoptosisScience, 1998
- Interferons and the tumor cellBiotherapy, 1996
- Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoproteinInternational Journal of Cancer, 1995